Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

By Wendy H. Schacht

Public interest in approaches that might provide prescription drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. In the current debate, some argue that the government's financial, scientific, and/or clinical support of health-related research and development (R&D) entitles the public to commensurate considerations in the prices charged for any resulting drugs. Others view government intervention in price decisions based upon initial federal funding as contrary to a long-term trend of government promotion of innovation, technological advancement, and the commercialization of technology by the business community leading to new products and processes for the marketplace.

• Format: Paperback
• Language: English
• ISBN: 1288670133
• ISBN13: 9781288670130
• Release Date: January 2013
• Publisher: Bibliogov
• Length: 38 Pages
• Weight: 0.19 lbs.
• Dimensions: 0.1" x 7.4" x 9.7"